OR AKIVA, Israel, June 2 /PRNewswire-FirstCall/ -- ITGI Medical, Ltd. (TASE: ITGI) announced today the first commercial use of the CE certified Over and Under(R) Pericardium Covered Stent (PCS) in the UK
Over and Under(R) is a stent 100% covered with a heterologous tissue, designed to set a barrier between the coronary blood vessel wall and its lumen. It is intended for situations such as degenerated Saphenous Vein Graft (SVG), aneurysms and perforations.
The first Over and Under(R) PCS commercial implantation and first implantation in the UK was performed at the Royal Bournemouth Hospital whose Percutaneous Coronary Intervention Leader is Dr. Suneel Talwar and the procedure was performed by the Cath Lab director Dr. Rosie Swallow. The medical team granted the procedure as a success due to the special characteristics of the stent and the ease at which the stent was delivered to the lesion.
A pilot study designed to compare the deliverability of a PTFE covered stent vs. Over and Under(R) PCS was presented by Dr. Haim Danenberg, Head of Interventional Cardiology Unit and the company's medical director, at the annual EuroPCR meeting. Study was performed in phantom and porcine coronaries. Over and Under(R) PCS appeared to be significantly superior in deliverability in both model systems.
At its initial step, ITGI launched Over and Under(R) PCS in England, in collaboration with Pyramed, the UK distributor. "We are very pleased with Pyramed's marketing. They have recently purchased the stents and already managed to initiate its use," commented Efri Argaman, CEO of ITGI Medical, "The medical team's satisfaction strengthens our belief that Over and Under(R) PCS ushers in a new era for interventional medicine."
About Over and Under(R)
Over and Under(R) is a unique stent, first in a series of heterologous
tissue covered stents, designed to set a barrier between the blood vessel
wall and its lumen. Over and Under(R) PCS is indic
|SOURCE ITGI Medical LTD|
Copyright©2008 PR Newswire.
All rights reserved